Funding for this research was provided by:
Takeda Pharmaceutical Company
This article is maintained by: Elsevier
Article Title: Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/J.HTCT.2020.07.005
Content Type: article
Copyright: © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.